Clinical Trials in Netherlands

• Hypoxic ventilatory response (HVR): Effect of Esketamine Ended
  2023-504229-37-00 Phase IV healthy volunteers Leiden University Medical Center
• A Study Evaluating Pharmacokinetic Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Stage III and Stage IV … Ended
  2022-502620-49-00 Resected Melanoma Stage III or Stage IV Amgen Inc.
• DiEtary Sodium Intake effects on ertugliflozin-induced changes in GFR, reNal oxygenation and systemic hemodynamics: the DESIGN study, a rand… Ended
  2023-510257-42-01 Phase IV Type 2 diabetes Amsterdam UMC
• Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD (ACTIVATE study) Ended
  2022-501783-18-00 Phase II Parkinson’s Disease Bial R&D Investments S.A.
• SAD and MAD of VENT-02 in healthy volunteers Ended
  2023-505546-26-00 Phase I Neuroinflammatory and neurodegenerative diseases Ventus Therapeutics U.S. Inc.
• Withdrawal of Tiratricol Treatment in Males with Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency): A Double-blind, Randomized, Pla… Ended
  2024-516124-34-00 Phase III Monocarboxylate Transporter 8 (MCT8) deficiency Rare Thyroid Therapeutics International AB
• Effect of a pain killer on breathing and another drug that stimulates breathing Ended
  2023-503912-34-00 Phase III/IV none, healthy subjects only Leiden University Medical Center
• A Study to Evaluate the Efficacy and Safety of Astegolimab in Patients with Chronic Obstructive Pulmonary Disease Ended
  2022-502234-70-00 Phase III Chronic Obstructive Pulmonary Disease (COPD) F. Hoffmann-La Roche AG
• An open-label, single-dose phase 1 study to evaluate the Absorption, Metabolism, and Excretion of [14C]-AZ-3102 in Healthy Male Subjects Ended
  2023-504916-14-00 Phase I (Other) Glycosphingolipid lysosomal storage disorders Azafaros B.V.
• Phase I/II study with galunisertib combined with capecitabine in patients with advanced chemotherapy resistant colorectal cancer with perito… Ended
  2024-518980-37-00 Phase I/II colorectal cancer Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
• Safety and efficacy of NMD670 in ambulatory adult patients with Type 3 spinal muscular atrophy (SYNAPSE-SMA) Ended
  2024-516321-31-00 Phase II Type 3 spinal muscular atrophy NMD Pharma A/S
• A PHASE 1 STUDY TO ASSESS THE MASS BALANCE, PHARMACOKINETICS, AND METABOLISM OF ORAL [14C]-ZIPALERTINIB IN HEALTHY ADULT MALE SUBJECTS Ended
  2023-505085-28-00 Phase I (Other) Cancer Taiho Oncology Inc.
• Long-term Safety and Efficacy of Efavaleukin Alfa in Subjects With Moderately to Severely Active Ulcerative Colitis Ended
  2023-506046-24-00 Phase II Ulcerative Colitis (UC) Amgen Inc.
• Phase 1 Study of BMS-986416 with and without Nivolumab in Solid Tumors Ended
  2022-501317-31-00 Solid tumor Bristol-Myers Squibb International Corporation
• CC-122 Rollover Study Ended
  2022-501855-97-00 Phase I (Other) Multiple Myeloma, Follicular Lymphoma, Diffuse Large B-Cell … Celgene Corp.
• A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors Ended
  2024-517150-10-00 Phase I (FiH) Cancer Ascendis Pharma Oncology Division A/S
• Pharmacokinetic study of minocycline in patients with nontuberculous mycobacterial disease Ended
  2024-517758-87-00 Nontuberculous mycobacterial disease Radboud universitair medisch centrum Stichting
• A 24-month study evaluating physical activity and joint health in patients 12 years and older, with severe haemophilia A treated once weekly… Ended
  2022-500275-31-00 Phase III Haemophilia A Swedish Orphan Biovitrum AB (publ)
• ARTEMIS: A Phase 3 Study of Ravulizumab to Protect Patients with Chronic Kidney Disease (CKD) from Cardiac Surgery Associated Acute Kidney … Ended
  2022-501802-36-00 Phase III Prevention of cardiac surgery associated acute kidney injury Alexion Pharmaceuticals Inc.
• A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (S… Ended
  2022-501752-29-00 Phase III Hidradenitis Suppurativa Incyte Corp.
• A Phase 2, Single-Blind, Placebo-Controlled Trial to Evaluate the Photoparoxysmal Electroencephalogram Response, Safety, Tolerability, and P… Ended
  2023-504803-10-00 Phase II IPS induced photoparoxysmal electroencephalogram response (I… Praxis Precision Medicines Inc.
• ABTECT-1 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -1 Ended
  2022-500535-36-01 Phase III Moderately to severely active ulcerative colitis Abivax
• A clinical trial in healthy people to look at how the body processes RO7268489 over time and when taken before or after a meal Ended
  2023-503528-25-00 Phase I (Other) There is no medical condition being investigated. This is a … F. Hoffmann-La Roche AG
• MERCURI-2 Ended
  2024-515260-31-00 Phase IV AKI Stichting Amsterdam UMC

Showing 2,209–2,232 of 2,584 trials